07 March 2012

Draft Guidelines for Syndromic Surveillance Now Open for Comment

ISDS is pleased to present Draft Guidelines for Syndromic Surveillance Using Inpatient and Ambulatory Clinical Care EHR Data. These guidelines were developed as part of a new ISDS and Centers for Disease Control and Prevention (CDC) initiative to advance surveillance practice and further clarify Meaningful Use standards for public health syndromic surveillance (PHSS), specifically with regard to health data from hospital inpatient and ambulatory clinical care settings. This initiative aims to bring the entire stakeholder community together for a dialogue on leveraging existing public health resources and Meaningful Use investments for more timely and effective disease prevention, public health response, and health outcomes.

ISDS is requesting stakeholder feedback during a comment period between March 6, 2012 and April 2, 2012. Your comments will help to inform the final recommendation that will be used by the CDC and the Office of the National Coordinator (ONC) to clarify public health surveillance measures in future Meaningful Use stages.

Please submit your comments via an online survey (link below), or you may also send your feedback to Becky Zwickl, ISDS Public Health Analyst, at bzwickl@syndromic.org.
For more information on ISDS's Meaningful Use efforts, visit the Meaningful Use webpage and the current ISDS Meaningful Use project webpage


Thank you! Your input is greatly appreciated.

3 comments:

  1. Individual insurance plans issued after March, cannot deny insurance or deny coverage for certain services to children based on per-existing conditions. Thanks a lot.
    hcg1234

    ReplyDelete
  2. Introduce new business. The new business will consist of new ideas and new topics that have not been previously discussed. During the new business segment it is important to get feedback and comments from other church members or board members. Thanks.
    Regards,
    how to weight gain

    ReplyDelete
  3. Systems that can automate the process of identifying adverse drug events, are currently being used, and are being compared to traditional written reports of such events. These systems intersect with the field of medical informatics, and are rapidly becoming adapted by hospitals and endorsed by institutions that oversee healthcare providers. Thanks.
    Regards,
    ultimate weight gainer

    ReplyDelete